Abstract: Analytical expressions that have been derived to calculate ac resistance and losses of magnetic devices at high frequencies have primarily used a one-dimensional approximation, and have used ...
In his column “Acrademics,” Alexandre Acra ’26 sheds light on the ins and outs of Stanford and Silicon Valley culture. Dear Acrademics, The world around us seems to be losing rigor and specificity by ...
IND application for Descartes-08 in myositis accepted by FDA; seamless adaptive clinical trial offering potential opportunity for a single pivotal trial expected to commence in 1H26 Phase 1/2 ...
hal-cgp is an extensible pure Python library implementing Cartesian genetic programming to represent, mutate and evaluate populations of individuals encoding symbolic expressions targeting ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis (MG ...
NEW YORK--(BUSINESS WIRE)--Cartesian Growth Corporation III (the “Company”) announced today the closing of its initial public offering of 27,600,000 units, including 3,600,000 units pursuant to the ...
Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25 Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol Assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results